The UK Department of Health and Social Care announced on Monday that it will roll out two new rapid COVID-19 […]
Tackling Disease-Related Repeat Expansion Analysis – Marzia Rossato What is the Dark Genome? The dark genome refers to parts of […]
Sequenced genomes retain a surprisingly large number of “dark” regions – sections that have proven difficult to characterise via short-read […]
On Thursday 18th June at 4pm BST/ 11am EST, Front Line Genomics is bringing you an interactive discussion from global […]
With a wealth of genomic technologies rapidly advancing with falling cost, implementing genomics into trials and routine care is becoming […]
This article has been based upon this blog post, written by Dr Karolina Szczesna. RNA sequencing (RNA-seq) uses next generation […]
* The following article is written with excerpts from the second edition of The Sequencing Buyer’s Guide. — The field […]
Last week, we asked the genomics community how they were shifting their focus to help fight the novel coronavirus. We […]
Singapore’s Health Sciences Authority has authorised clinical use of a new test for SARS-CoV-2 according to the Agency for Science, Technology, and Research (A*STAR).
Yesterday, a test developed by Co-diagnostics for the detection of SARS-CoV-2, received CE marking as the virus nears “pandemic” status. CE-IVD marking indicates that the IVD conforms with relevant EU directives regarding the health and safety of the product.